Erythromycin estolate is an aminoglycoside sulfate salt and an erythromycin derivative. Among its listed roles, it functions as a enzyme inhibitor. It includes a erythromycin A 2′-propanoate. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as anti-infectives. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Eritroger and Stellamicina. Its PubChem CID is 441371.
Erythromycin estolate
| CAS No | 3521-62-8 |
|---|---|
| Molecular Formula | C52H97NO18S |
| Molecular Weight | 1056.4 g/mol |
| Synonyms | [(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate;dodecyl hydrogen sulfate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Erythromycin estolate is an aminoglycoside sulfate salt and an erythromycin derivative. Among its listed roles, it functions as a enzyme inhibitor. It includes a erythromycin A 2'-propanoate.
The listed CAS number is 3521-62-8.
The listed molecular formula is C52H97NO18S.
The listed molecular weight is 1056.4 g/mol.
[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate;dodecyl hydrogen sulfate.
The source lists Eritroger and Stellamicina.